Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy

EPMA Journal

Volumn 3, Issue 1, 2012, Pages 9-

  Borisow, Nadja ^a   Döring, Andrea ^a   Pfueller, Caspar F ^a   Paul, Friedemann ^a   Dörr, Jan ^a   Hellwig, Kerstin ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ESTRADIOL; FINGOLIMOD; GAMMA INTERFERON; GESTAGEN; GLATIRAMER; GLUCOCORTICOID; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MITOXANTRONE; NATALIZUMAB; ORAL CONTRACEPTIVE AGENT; OXYBUTYNIN; PREDNISOLONE;

AGE DISTRIBUTION; ANEMIA; BREAST FEEDING; CD4 CD8 RATIO; CESAREAN SECTION; CHILDBIRTH; CLUBFOOT; CONCEPTION; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL MALFORMATION; DISEASE COURSE; DISEASE EXACERBATION; DOWN SYNDROME; DRUG APPROVAL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCARDIAL CUSHION DEFECT; EPIDURAL ANESTHESIA; FALLOT TETRALOGY; FAMILY PLANNING; FATIGUE; FEMALE INFERTILITY; FETUS DISEASE; FORCEPS DELIVERY; HORMONE BLOOD LEVEL; HUMAN; HYDROCEPHALUS; HYPOSPADIAS; IMMUNITY; INFERTILITY THERAPY; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; LACTATION; LEUKOPENIA; LOW BIRTH WEIGHT; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT DECISION MAKING; PERINATAL PERIOD; PERSONALIZED MEDICINE; PHYSICAL DISABILITY; PIERRE ROBIN SYNDROME; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; PULMONARY VALVE STENOSIS; RELAPSE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SHAME; SIDE EFFECT; SOLITARY KIDNEY; SPONTANEOUS ABORTION; STILLBIRTH; SYNDROME VACTERL; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VACUUM EXTRACTION; X CHROMOSOME ABERRATION;

EID: 84870066238     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-3-9     Document Type: Review

References (92)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
2. Milligan NM, Newcombe R, Compston DA. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 1987, 50:511-516. 10.1136/jnnp.50.5.511, 1031960, 3295122.
3. Thrower BW. Relapse management in multiple sclerosis. Neurologist 2009, 15:1-5. 10.1097/NRL.0b013e31817acf1a, 19131851.
4. Buck D, Hemmer B. Treatment of multiple sclerosis: current concepts and future perspectives. J Neurol 2011, 258:1747-1762. 10.1007/s00415-011-6101-2, 21637950.
5. Mendes A, Sá MJ. Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works. Arq Neuropsiquiatr 2011, 69:536-543. 10.1590/S0004-282X2011000400024, 21755136.
6. Del Santo F, Maratea D, Fadda V, Trippoli S, Messori A. Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis. Eur J Clin Pharmacol 2012, 68:441-448. 10.1007/s00228-011-1141-1, 22057838.
7. Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I. Natalizumab for relapsing remitting multiple sclerosis. Cochrane Database Syst Rev 2011,
8. Scott LJ, Figgitt DP. Mitoxantrone: a review of its use in multiple sclerosis. CNS Drugs 2004, 18:379-396. 10.2165/00023210-200418060-00010, 15089110.
9. Kappos L, Traboulsee A, Constantinescu C, Erälinna J-P, Forrestal F, Jongen P, Pollard J, Sandberg-Wollheim M, Sindic C, Stubinski B, Uitdehaag B, Li D. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology 2006, 67:944-953. 10.1212/01.wnl.0000237994.95410.ce, 17000959.
10. Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinsky J. Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler 2010, 16:342-350. 10.1177/1352458509358088, 2850588, 20106943.
11. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006, 13:700-722. 10.1111/j.1468-1331.2006.01342.x, 16834700.
12. Hein T, Hopfenmüller W. Hochrechnung der zahl an multiple sklerose erkrankten patienten in Deutschland. Nervenarzt 2000, 71:288-294. 10.1007/s001150050559, 10795096.
13. Koutsouraki E, Costa V, Baloyannis S. Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010, 22:2-13. 10.3109/09540261003589216, 20233110.
14. Prunty M, Sharpe L, Butow P, Fulcher G. The motherhood choice: themes arising in the decision-making process for women with multiple sclerosis. Mult Scler 2008, 14:701-704. 10.1177/1352458507086103, 18566034.
15. Schapira K, Poskanzer DC, Newell DJ, Miller H. Marriage, pregnancy and multiple sclerosis. Brain 1966, 89:419-428. 10.1093/brain/89.3.419, 5921125.
16. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 1998, 339:285-291. 10.1056/NEJM199807303390501, 9682040.
17. Payne D, McPherson KM. Becoming mothers. Multiple sclerosis and motherhood: a qualitative study. Disabil Rehabil 2010, 32:629-638. 10.3109/09638280903204708, 20205575.
18. Verdier-Taillefer MH, Alperovitch A. The relationship of patients' sex to reproduction in multiple sclerosis. J Epidemiol Community Health 1990, 44:77. 1060603, 2348156.
19. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995, 118:253-261. 10.1093/brain/118.1.253, 7895009.
20. Nielsen NM, Westergaard T, Rostgaard K, Frisch M, Hjalgrim H, Wohlfahrt J, Koch-Henriksen N, Melbye M. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol 2005, 162:774-778. 10.1093/aje/kwi280, 16120694.
21. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996, 119:449-455. 10.1093/brain/119.2.449, 8800940.
22. Carton H, Vlietinck R, Debruyne J, De Keyser J, D'Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997, 62:329-333. 10.1136/jnnp.62.4.329, 1074086, 9120443.
23. Prokopenko I, Montomoli C, Ferrai R, Musu L, Piras ML, Ticca A, Murgia BS, Bernardinelli L. Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepidemiology 2003, 22:290-296. 10.1159/000071192, 12902624.
24. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988, 38:990-991. 10.1212/WNL.38.6.990, 3368082.
25. Compston A. The genetic epidemiology of multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 1999, 354:1623-1634. 10.1098/rstb.1999.0507, 1692683, 10603615.
26. Dyment DA, Yee IM, Ebers GC, Sadovnick AD, . Canadian Collaborative Study Group Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006, 77:258-259. 10.1136/jnnp.2005.063008, 2077589, 16421134, Canadian Collaborative Study Group.
27. Ebers GC, Sadovnick AD, Risch NJ, . Canadian Collaborative Study Group A genetic basis for familial aggregation in multiple sclerosis. Nature 1995, 377:150-151. 10.1038/377150a0, 7675080, Canadian Collaborative Study Group.
28. Alonso A, Clark CJ. Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence. J Neurol Sci 2009, 286:73-75. 10.1016/j.jns.2009.04.038, 19427649.
29. Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55:848-854. 10.1212/WNL.55.6.848, 10994007.
30. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998, 105:1296-1299. 10.1111/j.1471-0528.1998.tb10008.x, 9883921.
31. D'hooghe MB, Haentjens P, Nagels G, D'Hooghe T, De Keyser J. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol 2012, 259:855-861. 10.1007/s00415-011-6267-7, 21993617.
32. Holmqvist P, Hammar M, Landtblom A-M, Brynhildsen J. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 2010, 94:2835-2837. 10.1016/j.fertnstert.2010.06.045, 20807659.
33. Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernán MA. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005, 62:1362-1365. 10.1001/archneur.62.9.1362, 16157743.
34. Hellwig K, Brune N, Haghikia A, Müller T, Schimrigk S, Schwödiauer V, Gold R. Reproductive counseling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand 2008, 118:24-28. 10.1111/j.1600-0404.2007.00978.x, 18205883.
35. Jalkanen A, Alanen A, Airas L, . Finnish Multiple Sclerosis and Pregnancy Study Group Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010, 16:950-955. 10.1177/1352458510372629, 20542921, Finnish Multiple Sclerosis and Pregnancy Study Group.
36. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences?. Mult Scler 2006, 12:209-214. 10.1191/135248506ms1253oa, 16629425.
37. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999, 5:418-427.
38. Sipski ML, Behnegar A. Neurogenic female sexual dysfunction: a review. Clin Auton Res 2001, 11:279-283. 10.1007/BF02332972, 11758793.
39. Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D, Cazzato G. Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci 2001, 187:1-5. 10.1016/S0022-510X(01)00493-2, 11440738.
40. Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med 1989, 226:241-244. 10.1111/j.1365-2796.1989.tb01387.x, 2809499.
41. Safarinejad MR. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J Neuroendocrinol 2008, 20:1368-1375. 10.1111/j.1365-2826.2008.01791.x, 19094084.
42. Nielsen NM, Jørgensen KT, Stenager E, Jensen A, Pedersen BV, Hjalgrim H, Kjær SK, Frisch M. Reproductive history and risk of multiple sclerosis. Epidemiology 2011, 22:546-552. 10.1097/EDE.0b013e31821c7adc, 21516039.
43. Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994, 96:38-41. 10.1016/0303-8467(94)90027-2, 8187380.
44. Albrecht P, Fischer D, Moser A. Multiple sclerosis and pregnancy: what does the patient think? A questionnaire study. BMC Res Notes 2010, 3:91. 10.1186/1756-0500-3-91, 2853552, 20361873.
45. Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990, 47:738-742. 10.1001/archneur.1990.00530070026007, 1972617.
46. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 1988, 259:3441-3443. 10.1001/jama.1988.03720230051029, 3373681.
47. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis-a 3-year prospective study. J Neurol 1994, 241:228-233. 10.1007/BF00863773, 8195822.
48. Finkelsztejn A, Fragoso YD, Ferreira ML, Lana-Peixoto MA, Alves-Leon SV, Gomes S, Damasceno BP, Mendes MF, Salgado PR, Correa EC, Comini-Frota ER, Diniz DS, Gama PD, Kaimen-Maciel DR, Morales RR, Arruda WO, Grzesiuk AK, Khouri JM, Lopes JS, Rocha CF, Domingues R, Gonçalves MV, Lorenti MA, Parolin MK, Siquineli F, Tosta ED, Brooks JB, Gallina AS, Melges LD, Ruocco HH. The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2011, 113:277-280. 10.1016/j.clineuro.2010.11.016, 21159421.
49. Salemi G, Callari G, Gammino M, Battaglieri F, Cammarata E, Cuccia G, D'Amelio M, Lupo I, Ragonese P, Savettieri G. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 2004, 110:23-26. 10.1111/j.1600-0404.2004.00270.x, 15180803.
50. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, . The Pregnancy In Multiple Sclerosis Group Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004, 127:1353-1360. 10.1093/brain/awh152, 15130950, The Pregnancy In Multiple Sclerosis Group.
51. Neuteboom RF, Janssens AC, Siepman TA, Hoppenbrouwers IA, Ketelslegers IA, Jafari N, Steegers EA, de Groot CJ, Hintzen RQ. Pregnancy in multiple sclerosis: clinical and self-report scales. J Neurol 2012, 259:311-317. 10.1007/s00415-011-6186-7, 3268991, 21811805.
52. Saraste M, Väisänen S, Alanen A, Airas L, . Finnish Multiple Sclerosis and Pregnancy Study Group Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med 2007, 4:45-55. 10.1016/S1550-8579(07)80008-8, 17584627, Finnish Multiple Sclerosis and Pregnancy Study Group.
53. Laplaud DA, Leray E, Barrière P, Wiertlewski S, Moreau T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006, 66:1280-1281. 10.1212/01.wnl.0000208521.10685.a6, 16636258.
54. Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S, Gold R. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008, 255:592-593. 10.1007/s00415-008-0607-2, 18408881.
55. Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009, 61:65-68. 10.1159/000177937, 19039223.
56. van der Kop ML, Pearce MS, Dahlgren L, Synnes A, Sadovnick D, Sayao AL, Tremlett H. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011, 70:41-50. 10.1002/ana.22483, 21710652.
57. Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005, 65:1961-1963. 10.1212/01.wnl.0000188898.02018.95, 16380620.
58. Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurol Scand Suppl 2006, (Suppl 183):51-54.
59. Finkelsztejn A, Brooks JB, Paschoal FM, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011, 118:790-797. 10.1111/j.1471-0528.2011.02931.x, 21401856.
60. Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 2002, 186:446-452. 10.1067/mob.2002.120502, 11904605.
61. Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB, Van Den Eeden SK, Nelson LM. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009, 66:958-963.
62. Haas J, Hommes OR. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler 2007, 13:900-908. 10.1177/1352458506075654, 17881400.
63. Hellwig K, Haghikia A, Agne H, Beste C, Gold R. Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Arch Neurol 2009, 66:1580-1581.
64. Langer-Gould A, Gupta R, Huang S, Hagan A, Atkuri K, Leimpeter AD, Albers KB, Greenwood E, Van Den Eeden SK, Steinman L, Nelson LM. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch Neurol 2010, 67:51-57. 10.1001/archneurol.2009.304, 20065129.
65. Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP, . MS Study Group of the Italian Neurological Society Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011, 77:145-150. 10.1212/WNL.0b013e318224afc9, 21734184, MS Study Group of the Italian Neurological Society.
66. Airas L, Jalkanen A, Alanen A, Pirttilä T, Marttila RJ. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 2010, 75:474-476. 10.1212/WNL.0b013e3181eb5860, 20679640.
67. Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005, 65:807-811. 10.1212/01.wnl.0000180575.77021.c4, 16186517.
68. Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M, . MS Study Group of the Italian Neurological Society Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology 2010, 75:1794-1802. 10.1212/WNL.0b013e3181fd62bb, 21079181, MS Study Group of the Italian Neurological Society.
69. Hellwig K, Gold R. Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis. J Neurol 2011, 258:502-503. 10.1007/s00415-010-5758-2, 20878174.
70. Sandberg-Wollheim M, Alteri E, Moraga MS, Kornmann G. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler 2011, 17:423-430. 10.1177/1352458510394610, 21220368.
71. Hellwig K, Agne H, Gold R. Interferon beta, birth weight and pregnancy in multiple sclerosis. J Neurol 2009, 256:830-831. 10.1007/s00415-009-5014-9, 19240959.
72. Patti F, Cavallaro T, Lo Fermo S, Nicoletti A, Cimino V, Vecchio R, Laisa P, Zarbo R, Zappia M. Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?. J Neurol 2008, 255:1250-1253. 10.1007/s00415-008-0909-4, 18677640.
73. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005, 65:802-806. 10.1212/01.wnl.0000168905.97207.d0, 16093457.
74. Fragoso YD, Finkelsztejn A, Kaimen-Maciel DR, Grzesiuk AK, Gallina AS, Lopes J, Morales NM, Alves-Leon SV, de Almeida SM. Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series. CNS Drugs 2010, 24:969-976.
75. Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler 2009, 15:1037-1042. 10.1177/1352458509106543, 19692433.
76. Salminen HJ, Leggett H, Boggild M. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 2010, 257:2020-2023. 10.1007/s00415-010-5652-y, 20625758.
77. Hellwig K, Haghikia A, Gold R. Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 2010, 257:580-583. 10.1007/s00415-009-5376-z, 19936821.
78. Hoevenaren IA, de Vries LC, Rijnders RJ, Lotgering FK. Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases. Acta Neurol Scand 2011, 123:430-433. 10.1111/j.1600-0404.2010.01426.x, 21492099.
79. Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler 2011, 17:958-963. 10.1177/1352458511401944, 21613333.
80. Bayas A, Penzien J, Hellwig K. Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis. Acta Neurol Scand 2011, 124:290-292. 10.1111/j.1600-0404.2010.01480.x, 21943035.
81. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000, 62:385-392. 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z, 11091360.
82. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004, 18:93-101. 10.1016/j.reprotox.2003.10.007, 15013068.
83. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004, 115:3-9. 10.1016/j.ejogrb.2003.10.020, 15223156.
84. Nurmohamed L, Moretti ME, Schechter T, Einarson A, Johnson D, Lavigne SV, Erebara A, Koren G, Finkelstein Y. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol 2011, 205:533.e1-533.e3.
85. De Santis M, Straface G, Cavaliere AF, Rosati P, Batocchi AP, Caruso A. The first case of mitoxantrone exposure in early pregnancy. Neurotoxicology 2007, 28:696-697. 10.1016/j.neuro.2006.10.002, 17227680.
86. Hellwig K, Schimrigk S, Chan A, Epplen J, Gold R. A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis. J Neurol Sci 2011, 307:164-165. 10.1016/j.jns.2011.05.003, 21601225.
87. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004, 251:1133-1137.
88. Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, Cornu C, Confavreux C, . Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis Study Group The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci 2009, 286:114-118. 10.1016/j.jns.2009.08.056, 19758607, Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis Study Group.
89. de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 2004, 10:596-597. 10.1191/1352458504ms1079sr, 15471379.
90. Hellwig K, Beste C, Schimrigk S, Chan A. Immunomodulation and postpartum relapses in patients with multiple sclerosis. Ther Adv Neurol Disord 2009, 2:7-11. 10.1177/1756285608100416, 3002620, 21180639.
91. Twork S, Wirtz M, Schipper S, Klewer J, Bergmann A, Kugler J. Chronical illness and maternity: life conditions, quality of life and coping in women with multiple sclerosis. Qual Life Res 2007, 16:1587-1594. 10.1007/s11136-007-9268-3, 17917791.
92. Harrison T, Stuifbergen A. Disability, social support, and concern for children: depression in mothers with multiple sclerosis. J Obstet Gynecol Neonatal Nurs 2002, 31:444-453. 10.1111/j.1552-6909.2002.tb00067.x, 12146934.